We are international

Call the IMF Hotline. We are here for you. The IMF Office is open from 8:00AM - 5:00PM PST, Monday-Friday.

If you have a question, call the IMF InfoLine at (800) 452-CURE (800-452-2873) in the US and Canada. The InfoLine is open from 9:00 - 4:00 PT Monday - Friday. Elsewhere call (818) 487-7455. You can also contact us via the web.
IMF - Home Page
    next      view all

Learn Important 2015 Myeloma Updates on Living Well Teleconference
Join us for the next installment of the Living Well with Myeloma Teleconference Series, “Myeloma Updates 2015,” on Thursday, June 18 at 4 pm PT, 7 pm ET. The June teleconference will be presented by Dr. Brian Durie, IMF Chairman, who will recap important myeloma treatment and research trends after attending three major medical summits held around the world: the American Society of Clinical Oncology (ASCO), the European Hematology Association (EHA) and the International Myeloma Working Group (IMWG). Register now for the 60-minute teleconference, here.

Lifting the Veil of Hype Surrounding the Promise of Genomics
Has the promise of genetic research been overhyped? In his blog this week, IMF Chairman Dr. Brian Durie looks at this question, posed in a recent article by science writer David Dobbs. Years of disappointing genomic research has largely failed to halt the progression of most diseases. “We need a balance of caution and understanding before signing over all hope to big genomics,” writes Dr. Durie. To read blog click HERE.

Tune in to IMF Medicare Advantage Webinar on June 3
Please join IMF Advocacy team members on June 3, 2015 at 4 pm PT / 7 pm ET as we host an important webinar entitled "Medicare Advantage: An Overview." During this 60-minute webinar, Dr. Gretchen Jacobson of the Kaiser Family Foundation will present vital information about Medicare Advantage plans, and more specifically, explain the ways in which Advantage plans’ coverage differ from more traditional Medicare plans. If you or your family is interested in learning which types of coverage are best for you, don’t miss this webinar! To register, please click here.

The Tweets Have Been Tallied and We Want to Say Thanks!
Thank you to the many IMF social media followers who participated in the #DiscoverMyeloma campaign on Twitter, and of course, a big thanks to everyone at Takeda for their generous $30,000 donation! Takeda Oncology, a division of Takeda Pharmaceutical Company, ran a social media fundraising and awareness drive in March during Myeloma Awareness month, pledging $5 to the IMF for every tweet sent using the hashtag #DiscoverMyeloma. Well, the Tweets have been counted and there were 6,000 tweets (!) spreading the word, facts and resources about the fight against myeloma! “We’re so grateful to all for their daily participation and help in driving further awareness about myeloma with the larger community,” said Robin Tuohy, Senior Director of Support Groups for the IMF. “Now thanks to the combined efforts of each individual and the generosity of Takeda, the IMF has a wonderful donation to help us continue our mission to find a cure.”

Myeloma Immune Therapy Emerges as a Key Theme at ASCO 2015
In his blog this week, IMF Chairman Dr. Brian Durie reviews abstracts of the top myeloma studies to be presented at the 2015 annual meeting of the American Society of Clinical Oncology (ASCO). “Immune therapy in myeloma will likely dominate the news,” writes Dr. Durie of the event, which begins May 29th in Chicago. Click HERE to read his blog.

The IMF's Concise Review Has Been Revised!
The IMF is pleased to announce that we’ve published an updated version of our Concise Review of the Disease and Treatment Options for myeloma patients! The Concise Review is an overview of myeloma, with a discussion of pathophysiology, clinical features, and treatment options to help you better understand a diagnosis. The IMF serves myeloma patients and family members and provides a wide range of programs in the areas of research, education, support, and advocacy. To download the pdf, please click HERE.

Dr. Durie's Blog: Life Extension? No, Let's Shoot for Permanent Remission
In the two weeks since we lost one of our most beloved patients, Mike Katz, our inability to cure myeloma has been staring us in the face. While the extended lives of myeloma patients is something to be celebrated, we need decisively better drugs to achieve our goal of permanent remission. How do we set the bar high enough to achieve these great outcomes?

Living Well with Myeloma: Sustainable Wellness – An Integrative Approach to Transform Your Mind, Body, and Spirit teleconference
The next Living Well With Myeloma Teleconference is Thursday, May 7, 2015. The subject is one that has been “in the news” and a hot topic in the medical world: Sustainable Wellness. Our Speaker for this topic is Dr. Matt Mumber and he has put together an excellent presentation that we feel will be beneficial to you and your group members.

In Loving Memory of Our Dear Friend Mike Katz, Long-Term IMF Board Member and Leading Patient Advocate
As you know, this past weekend the IMF lost a long-standing Board member and friend, Michael Katz. He routinely inspired patients to take charge of their myeloma and brought myeloma patient advocacy to the forefront. He was a colleague and friend to patients and physicians alike. IMF President Susie Novis recalls the many accomplishments and special spirit that made Mike a hero for myeloma patients everywhere. Read the story here. http://bit.ly/1OJVeCD

The International Myeloma Foundation Mourns the Passing of Board of Directors Member, Patient Champion, Michael S. Katz

This weekend the IMF lost a founding Board member who brought myeloma patient advocacy to the forefront. "Susie and I lost a dear and wonderful friend,” said IMF Chairman Dr. Brian Durie. “Mike Katz routinely inspired patients to take charge of their myeloma—to understand what is going on and get questions answered. He was a colleague and friend to patients and physicians alike. Mike, we will all miss you, we love you and will remember you always."

    next      view all